FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Patricia Vusio

Research Profile

Procedures

Surface Plasmon Resonance

Chemicals & Drugs

Phenomena

Concepts & Ideas

Anatomy

Living Beings

Physiology

Signal Transduction

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Sandrine Théoleyre; S Kwan Tat; Patricia Vusio; Frédéric Blanchard; J Gallagher; S Ricard-Blum; Yannick Fortun; Marc Padrines; Françoise Rédini; Dominique Heymann
Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
Erwan mortier; Agnès Quéméner; Patricia Vusio; Inken Lorenzen; Yvan Boublik; Joachim Grötzinger; Ariane Plet; Yannick Jacques
Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins.
Catherine Rabu; Agnès Quéméner; Yannick Jacques; Klara Echasserieau; Patricia Vusio; François Lang
Production of recombinant human trimeric CD137L (4-1BBL). Cross-linking is essential to its T cell co-stimulation activity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Patricia Vusio (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Sandrine Théoleyre; S Kwan Tat; Patricia Vusio; Frédéric Blanchard; J Gallagher; S Ricard-Blum; Yannick Fortun; Marc Padrines; Françoise Rédini; Dominique Heymann
Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
Biochemical and biophysical research communications 2006;347(2):460-7.
2006: Erwan mortier; Agnès Quéméner; Patricia Vusio; Inken Lorenzen; Yvan Boublik; Joachim Grötzinger; Ariane Plet; Yannick Jacques
Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins.
The Journal of biological chemistry 2006;281(3):1612-9.
2005: Catherine Rabu; Agnès Quéméner; Yannick Jacques; Klara Echasserieau; Patricia Vusio; François Lang
Production of recombinant human trimeric CD137L (4-1BBL). Cross-linking is essential to its T cell co-stimulation activity.
The Journal of biological chemistry 2005;280(50):41472-81.
2004: Pierre-François Cartron; Tristan Gallenne; Gwenola Bougras; Fabien Gautier; Florence Manero; Patricia Vusio; Khaled Meflah; François M Vallette; Philippe Juin
The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA.
Molecular cell 2004;16(5):807-18.
2004: Sandrine Theoleyre; Yohann Wittrant; Séverine Couillaud; Patricia Vusio; Martine Berreur; C Dunstan; Frédéric Blanchard; Françoise Rédini; Dominique Heymann
Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor kappaB ligand and MAPK.
Biochimica et biophysica acta 2004;1644(1):1-7.
2003: Laurence Duplomb; Benjamin Chaigne-Delalande; Patricia Vusio; Sylvie Raher; Yannick Jacques; Anne Godard; Frédéric Blanchard
Soluble mannose 6-phosphate/insulin-like growth factor II (IGF-II) receptor inhibits interleukin-6-type cytokine-dependent proliferation by neutralization of IGF-II.
Endocrinology 2003;144(12):5381-9.
2003: Dimitri Harmegnies; Xiao-Ming Wang; Paul Vandenbussche; Arnaud Leon; Patricia Vusio; Joachim Grötzinger; Yannick Jacques; Erik Goormaghtigh; Bart Devreese; Jean Content
Characterization of a potent human interleukin-11 agonist.
The Biochemical journal 2003;375(Pt 1):23-32.
2003: Bernard Vanhove; Geneviève Laflamme; Flora Coulon; Marie Mougin; Patricia Vusio; Fabienne Haspot; Jérôme Tiollier; Jean-Paul Soulillou
Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody.
Blood 2003;102(2):564-70.
2002: Anahit Ghochikyan; Iovka Miltcheva Karaivanova; Michèle Lecocq; Patricia Vusio; Marie-Claire Arnaud; Marina Snapyan; Pierre Weigel; Laetitia Guével; Malcolm Buckle; Vehary Sakanyan
Arginine operator binding by heterologous and chimeric ArgR repressors from Escherichia coli and Bacillus stearothermophilus.
Journal of bacteriology 2002;184(23):6602-14.
2001: Karin Schleinkofer; Andrew J Dingley; I Tacken; M Federwisch; Gerhard Müller-Newen; Peter C Heinrich; Patricia Vusio; Yannick Jacques; Joachim Grötzinger
Identification of the domain in the human interleukin-11 receptor that mediates ligand binding.
Journal of molecular biology 2001;306(2):263-74.
2000: C Blanc; Patricia Vusio; Karin Schleinkofer; Olivier Boisteau; S Pflanz; Stéphane Minvielle; Joachim Grötzinger; Gerhard Müller-Newen; Peter C Heinrich; Yannick Jacques; Félix A Montero-Julian
Monoclonal antibodies against the human interleukin-11 receptor alpha-chain (IL-11Ralpha) and their use in studies of human mononuclear cells.
Journal of immunological methods 2000;241(1-2):43-59.
1999: Frédéric Blanchard; Laurence Duplomb; Sylvie Raher; Patricia Vusio; B Hoflack; Yannick Jacques; Anne Godard
Mannose 6-Phosphate/Insulin-like growth factor II receptor mediates internalization and degradation of leukemia inhibitory factor but not signal transduction.
The Journal of biological chemistry 1999;274(35):24685-93.
1998: Frédéric Blanchard; Sylvie Raher; Laurence Duplomb; Patricia Vusio; Vincent Pitard; Jean-Luc Taupin; Jean-François Moreau; B Hoflack; Stéphane Minvielle; Yannick Jacques; Anne Godard
The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor.
The Journal of biological chemistry 1998;273(33):20886-93.